Cargando…
Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American College of Chest Physicians. Published by Elsevier Inc.
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130147/ https://www.ncbi.nlm.nih.gov/pubmed/16354884 http://dx.doi.org/10.1016/S0012-3692(15)49656-4 |
| _version_ | 1783516944940400640 |
|---|---|
| author | Chu, Chung-Ming Chan, Kin-Sang |
| author_facet | Chu, Chung-Ming Chan, Kin-Sang |
| author_sort | Chu, Chung-Ming |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7130147 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2005 |
| publisher | The American College of Chest Physicians. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71301472020-04-08 Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome Chu, Chung-Ming Chan, Kin-Sang Chest Communications to the Editor The American College of Chest Physicians. Published by Elsevier Inc. 2005-12 2015-12-24 /pmc/articles/PMC7130147/ /pubmed/16354884 http://dx.doi.org/10.1016/S0012-3692(15)49656-4 Text en © 2005 The American College of Chest Physicians Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Communications to the Editor Chu, Chung-Ming Chan, Kin-Sang Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome |
| title | Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome |
| title_full | Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome |
| title_fullStr | Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome |
| title_full_unstemmed | Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome |
| title_short | Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome |
| title_sort | ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome |
| topic | Communications to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130147/ https://www.ncbi.nlm.nih.gov/pubmed/16354884 http://dx.doi.org/10.1016/S0012-3692(15)49656-4 |
| work_keys_str_mv | AT chuchungming ribavarinshouldbetestedinclinicaltrialsincombinationwithotherantiviralagentsforsevereacuterespiratorysyndrome AT chankinsang ribavarinshouldbetestedinclinicaltrialsincombinationwithotherantiviralagentsforsevereacuterespiratorysyndrome |